change – Page 314 – Communicable Diseases Research

Main Clinical Features of COVID-19 and Potential Prognostic and Therapeutic Value of the Microbiota in SARS-CoV-2 Infections

Microbiology

Published on 2020-06-052022-10-31
Journal: Frontiers in Microbiology [Category] COVID-19,

[키워드] ACE2 acute respiratory distress acute respiratory syndrome Analysis angiotensin-converting enzyme 2 antiviral immunity association Bacteria caused change changes in clinical clinical feature Clinical features coronavirus Coronavirus disease 2019 correlated COVID-19 COVID-19 patients determine Diagnosis digestive tract distribution ENhance Fatality rate gut microbiota help host cells identity immune cells immunopathology infect infecting interferon intestinal tract intestine lung microbial microbiota much lower nucleotide sequence outcome outcomes pandemic Patient peptides Potential predict receptor regulate respiratory virus SARS-CoV SARS-CoV-2 SARS-COV-2 infection SCFAs secretion syndrome Therapies Treatment turn value
[DOI] 10.3389/fmicb.2020.01302 PMC 바로가기 [Article Type] Microbiology

Adding Colchicine to the Antiretroviral Medication – Lopinavir/Ritonavir (Kaletra) in Hospitalized Patients with Non-Severe Covid-19 Pneumonia: A Structured Summary of a Study Protocol for a Randomized Controlled Trial

Letter

Published on 2020-06-052022-10-29
Journal: Trials [Category] Coronavirus, SARS,

[키워드] 1:1 added Adding anti-inflammatory effect Antibiotics anticipated antioxidant antioxidants antiretroviral blinded both group CDC center change Clinical course Clinical improvement Colchicine component Consensus Controlled COVID-19 COVID-19 infection COVID-19 patients digoxin dissemination dosage double blind double-blind study element enrolled equation estimate Final GFR glomerular filtration rate group help Hospital stay hospitalized COVID-19 patients hypersensitivity hypoxic in both group infected with COVID-19 Inflammation inflammatory disorders Inpatient interleukin-8 intubation invasive Iran Kaletra kidney transplant recipients Lopinavir/ritonavir lung Lung CT MDA mechanism Minerals Nasopharyngeal swab National number objective outcome oxidative stress Oxygenation pandemic parallel group participant pathologic pathway Patient patients percentage Pneumonia positive Prospective protocol QTc randomised randomised controlled trial randomization Randomized Rate Ratio receive recruited recruitment reducing reduction Registered RT -PCR Sample size serum creatinine status Tehran time tomography Trace element treat treated Treatment two group two groups Vitamin website WHO guideline with COVID-19
[DOI] 10.1186/s13063-020-04455-3 PMC 바로가기 [Article Type] Letter

On the origin and continuing evolution of SARS-CoV-2

Microbiology

Published on 2020-06-032022-10-30
Journal: National Science Review [Category] COVID-19,

Common-path interferometric label-free protein sensing with resonant dielectric nanostructures

Article

Published on 2020-06-022022-10-04
Journal: Light, Science & Applications [Category] 바이오마커,

Otolaryngology in the Time of Corona: Assessing Operative Impact and Risk During the COVID-19 Crisis

Special Section on COVID-19

Published on 2020-06-022022-10-29
Journal: Otolaryngology--Head and Neck Surgery [Category] COVID-19, MERS, SARS,

Flattening the Mental Health Curve: COVID-19 Stay-at-Home Orders Are Associated With Alterations in Mental Health Search Behavior in the United States

Original Paper

Published on 2020-06-012022-10-31
Journal: JMIR Mental Health [Category] COVID-19,

Consistency analysis of COVID-19 nucleic acid tests and the changes of lung CT

Research article

Published on 2020-06-012022-10-05
Journal: Journal of Clinical Virology [Category] SARS, 진단,

Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2

Review Article

Published on 2020-05-292022-10-04
Journal: Signal Transduction and Targeted Therapy [Category] MERS, SARS, 신약개발, 임상, 치료제,

[키워드] “cytokine storm” adaptive adaptive immune system approved biological processe cascade change chemokine Clinical management COVID-19 COVID-19 patients cytokine Cytokine storm Defense develop drugs dysregulation effective drug help highlight Host immune defense immune dysregulation immune response immune signaling pathway immune system immunopathology implicated Infectious diseases Inflammation Inflammatory innate response mechanism Mild molecular pathway pharmacological Prevent reflect SARS-CoV-2 SARS-COV-2 infection Severe case signaling pathway Spread stages standard care Supportive treatments systemic level therapeutic tissue damage treat Treatment triggered urgent investigation Vaccine viral infection virus virus entry widespread
[DOI] 10.1038/s41392-020-0191-1 PMC 바로가기 [Article Type] Review Article

Detection of air and surface contamination by SARS-CoV-2 in hospital rooms of infected patients

Article

Published on 2020-05-292022-10-04
Journal: Nature Communications [Category] MERS, SARS, 진단, 치료기술,

Psychological status and behavior changes of the public during the COVID-19 epidemic in China

Research Article

Published on 2020-05-292022-10-29
Journal: Infectious Diseases of Poverty [Category] COVID-19, MERS, SARS,

[키워드] Abnormalities activities affected age Analysis analysis of variance analyzed Anxiety Behavior changes change changes Characteristics chi-square tests China chose Cluster Commission Contact COVID-19 COVID-19 epidemic Depression Effect epidemiological evaluate Gender groups hygiene Infection inventory investigated knowledge majority measure media Novel coronavirus observé outbreak phobia pneumonia case preventive measure Psychological Psychological intervention psychological status Psychological stress public health Public psychological status questionnaire recruited reduced reported required respondent Result scale significantly spring Stress suffered t -test the epidemic WeChat Wuhan
[DOI] 10.1186/s40249-020-00678-3 PMC 바로가기 [Article Type] Research Article